Cleared Special

K003724 - CBMYOTHERM XP CARDIOPLEGIA DELIVERY SYSTEM WITH CARMEDA BIOACTIVE SURFACE, MODELS CB41 AND CB41-B (FDA 510(k) Clearance)

Dec 2000
Decision
17d
Days
Class 2
Risk

K003724 is an FDA 510(k) clearance for the CBMYOTHERM XP CARDIOPLEGIA DELIVERY SYSTEM WITH CARMEDA BIOACTIVE SURFACE, MODELS CB41 AND CB41-B. This device is classified as a Heat-exchanger, Cardiopulmonary Bypass (Class II - Special Controls, product code DTR).

Submitted by Medtronic Vascular (Minneapolis, US). The FDA issued a Cleared decision on December 21, 2000, 17 days after receiving the submission on December 4, 2000.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4240.

Submission Details

510(k) Number K003724 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 04, 2000
Decision Date December 21, 2000
Days to Decision 17 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DTR — Heat-exchanger, Cardiopulmonary Bypass
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4240